HK1157190A1 - Isolated renal cells and uses thereof - Google Patents

Isolated renal cells and uses thereof

Info

Publication number
HK1157190A1
HK1157190A1 HK11111451.6A HK11111451A HK1157190A1 HK 1157190 A1 HK1157190 A1 HK 1157190A1 HK 11111451 A HK11111451 A HK 11111451A HK 1157190 A1 HK1157190 A1 HK 1157190A1
Authority
HK
Hong Kong
Prior art keywords
renal cells
isolated renal
methods
cell populations
isolated
Prior art date
Application number
HK11111451.6A
Other languages
English (en)
Inventor
Sharon Presnell
Andrew Bruce
Shay M Wallace
Sumana Choudhury
Russell W Kelley
Manuel J Jayo
Eric S Werdin
Patricia D Tatsumi
Jessica J Reinsch
Timothy A Bertram
Oluwatoyin A Knight
H Scott Rapoport
Roger M Ilagan
Original Assignee
Tengion Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tengion Inc filed Critical Tengion Inc
Publication of HK1157190A1 publication Critical patent/HK1157190A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/14—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10—Mechanical dissociation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
HK11111451.6A 2008-11-12 2011-10-25 Isolated renal cells and uses thereof HK1157190A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US11403008P 2008-11-12 2008-11-12
US11402508P 2008-11-12 2008-11-12
US20105608P 2008-12-05 2008-12-05
US20130508P 2008-12-08 2008-12-08
US12131108P 2008-12-10 2008-12-10
PCT/US2009/006085 WO2010056328A1 (en) 2008-11-12 2009-11-12 Isolated renal cells and uses thereof

Publications (1)

Publication Number Publication Date
HK1157190A1 true HK1157190A1 (en) 2012-06-29

Family

ID=41625133

Family Applications (2)

Application Number Title Priority Date Filing Date
HK11111451.6A HK1157190A1 (en) 2008-11-12 2011-10-25 Isolated renal cells and uses thereof
HK14110826A HK1197267A1 (en) 2008-11-12 2014-10-29 Isolated renal cells and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK14110826A HK1197267A1 (en) 2008-11-12 2014-10-29 Isolated renal cells and uses thereof

Country Status (10)

Country Link
US (5) US8318484B2 (xx)
EP (3) EP3388509A1 (xx)
JP (5) JP5974233B2 (xx)
KR (5) KR102357077B1 (xx)
CN (2) CN102271692B (xx)
AU (5) AU2009314552B2 (xx)
CA (1) CA2743459A1 (xx)
HK (2) HK1157190A1 (xx)
NZ (2) NZ601862A (xx)
WO (1) WO2010056328A1 (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008262333B2 (en) 2007-06-08 2014-07-17 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
WO2010057013A1 (en) 2008-11-14 2010-05-20 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
AU2010319385A1 (en) 2009-11-12 2012-05-17 Regenmedtx, Llc Rational design of regenerative medicine products
NZ603482A (en) * 2010-05-12 2014-11-28 Tengion Inc Bioactive renal cells
TWI607757B (zh) * 2010-11-10 2017-12-11 英瑞金公司 治療製劑
EP2773955B1 (en) * 2011-11-04 2018-07-18 inRegen Drug screening and potency assays
CN117660296A (zh) * 2012-10-24 2024-03-08 普罗基德尼 肾细胞群及其用途
JP6509745B2 (ja) * 2013-01-25 2019-05-08 エックスセル・バイオサイエンシズ・インコーポレイテッド 標的細胞の選択的富化のための方法、組成物、キット、及びシステム
WO2014182885A2 (en) * 2013-05-08 2014-11-13 Tengion, Inc. Organoids comprising isolated renal cells and uses thereof
KR20180081561A (ko) * 2015-11-06 2018-07-16 벤타나 메디컬 시스템즈, 인코포레이티드 대표 진단법
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease
EP3490570A1 (en) * 2016-07-29 2019-06-05 Deepak Jain Bioactive renal cells for the treatment of chronic kidney disease
CA3065790A1 (en) * 2017-06-21 2018-12-27 Timothy A. Bertram Immunoprivileged bioactive renal cells for the treatment of kidney disease
CN108251352B (zh) * 2018-02-01 2021-07-06 伯仕利生物科技发展（盐城）有限公司 一种血管内皮干细胞的培养方法
CN115210361A (zh) * 2020-03-04 2022-10-18 玛土撤拉有限公司 促红细胞生成素产生能力增强的成纤维细胞
WO2021176420A1 (en) 2020-03-06 2021-09-10 ReGenesys BVBA Biocompatible scaffolds for culturing post natal progenitor cells
CN112107600B (zh) * 2020-10-26 2024-04-05 张哲� 一种治疗色素沉着性疾病的纳米制剂及其制备方法
CN114703120B (zh) * 2022-03-17 2024-02-02 上海纽仁生物医药科技有限公司 一种动物神经系统血管平滑肌细胞单细胞的分离方法
CN114507642B (zh) * 2022-03-17 2024-02-02 上海纽仁生物医药科技有限公司 一种动物神经系统周细胞单细胞的分离方法
WO2024006918A2 (en) * 2022-06-29 2024-01-04 Prakash Narayan Selected renal cell populations, characteristics and uses thereof

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045849B2 (ja) * 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US5266480A (en) * 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US5032508A (en) 1988-09-08 1991-07-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5863531A (en) 1986-04-18 1999-01-26 Advanced Tissue Sciences, Inc. In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US4769037A (en) * 1986-10-28 1988-09-06 Midcalf Robert J Artificial replacement kidney implant and method of dialyzing blood
GB8722854D0 (en) * 1987-09-29 1987-11-04 Hardy S M Implantable artificial kidney
US5085629A (en) * 1988-10-06 1992-02-04 Medical Engineering Corporation Biodegradable stent
CN1053698C (zh) 1989-01-19 2000-06-21 南京大学 细胞培养生产促红细胞生成素的方法
CA2031532C (en) 1989-04-25 2003-02-25 Joseph P. Vacanti Method for implanting large volumes of cells on polymeric matrices
US4996154A (en) * 1989-05-04 1991-02-26 Millipore Corporation Method for growing cellular tissue
WO1993007913A1 (en) 1991-10-24 1993-04-29 Children's Medical Center Corporation Neomorphogenesis of urological structures in vivo from cell culture
NZ245015A (en) * 1991-11-05 1995-12-21 Transkaryotic Therapies Inc Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
US6410320B1 (en) * 1992-03-02 2002-06-25 The University Of Michigan Method and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
US5549674A (en) * 1992-03-02 1996-08-27 The Regents Of The University Of Michigan Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
US6060270A (en) * 1992-03-02 2000-05-09 The University Of Michigan Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
US5429938A (en) * 1992-03-02 1995-07-04 University Of Michigan Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules
US5545131A (en) * 1994-04-28 1996-08-13 White Eagle International Technologies, Lp Artificial kidney
ATE260076T1 (de) * 1996-09-05 2004-03-15 Childrens Medical Center Nierenprothese
US6673339B1 (en) * 1996-09-05 2004-01-06 Children's Medical Center Corporation Prosthetic kidney and its use for treating kidney disease
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
US6854003B2 (en) * 1996-12-19 2005-02-08 Hyundai Electronics America Video frame rendering engine
US5854006A (en) * 1997-03-28 1998-12-29 The University Of Virginia Gamma-glutamyl transpeptidase-specific antibody, prodrugs for the treatment of gamma-glutamyl transpeptidase-expressing tumors, and methods of administration thereof
US6224893B1 (en) 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
JP2004155788A (ja) * 1998-09-24 2004-06-03 Tanabe Seiyaku Co Ltd 腎疾患治療薬およびそのスクリーニング方法
US6777205B1 (en) * 1998-11-06 2004-08-17 Sterrenbeld Biotechnologie North America, Inc. Host cells expressing recombinant human erythropoietin
RU2248215C2 (ru) * 1999-05-11 2005-03-20 Орто-Макнейл Фармасьютикал, Инк. Фармакокинетическое и фармакодинамическое моделирование введения эритропоэтина
US20040167634A1 (en) * 1999-05-26 2004-08-26 Anthony Atala Prosthetic kidney and its use for treating kidney disease
ATE445837T1 (de) 1999-05-27 2009-10-15 Cmic Co Ltd Heilmittel für nierenkrankheiten und verfahren zum screenen selbiger
KR100369788B1 (ko) 1999-09-03 2003-01-29 동아제약 주식회사 재조합 인간 에리트로포이에틴의 제조방법
US6376244B1 (en) * 1999-12-29 2002-04-23 Children's Medical Center Corporation Methods and compositions for organ decellularization
US7326570B2 (en) * 2000-06-16 2008-02-05 The Regents Of The University Of California Induction of tubular morphogenesis using pleiotrophin
WO2002009792A1 (en) * 2000-07-28 2002-02-07 Anika Therapeutics, Inc. Bioabsorbable composites of derivatized hyaluronic acid
ES2272573T3 (es) * 2000-10-30 2007-05-01 Zymogenetics, Inc. Composiciones y metodos para mejorar la funcion renal.
WO2002061053A1 (en) 2001-01-31 2002-08-08 The General Hospital Corporation Renal stem cells and uses thereof
GB2392116A (en) * 2001-05-31 2004-02-25 Asahi Chemical Ind Method of separating and concentrating cells for kidney regeneration
US6784154B2 (en) * 2001-11-01 2004-08-31 University Of Utah Research Foundation Method of use of erythropoietin to treat ischemic acute renal failure
KR20050044507A (ko) 2001-11-16 2005-05-12 칠드런'즈 메디컬 센터 코포레이션 장기 기능의 확장
US20030180268A1 (en) * 2002-02-05 2003-09-25 Anthony Atala Tissue engineered construct for supplementing or replacing a damaged organ
MXPA04009234A (es) 2002-03-22 2005-01-25 Kissei Pharmaceutical Agente preventivo o terapeutico para enfermedades renales.
US8084424B2 (en) * 2003-04-09 2011-12-27 University Of Utah Research Foundation Compositions and methods related to erythropoietin
US20060153894A1 (en) * 2004-06-30 2006-07-13 Ragae Ghabrial Multi-compartment delivery system
KR20080075494A (ko) * 2005-09-21 2008-08-18 다스크 테크날러지, 엘엘씨 장기 및 조직 기능성을 위한 방법 및 조성물
AU2007212085B2 (en) * 2006-02-07 2011-11-17 Spinalcyte, Llc Methods and compositions for repair of cartilage using an in vivo bioreactor
CA2871840A1 (en) 2006-02-10 2007-08-23 Tengion, Inc. Scaffolds for organ reconstruction and augmentation
JPWO2007125916A1 (ja) * 2006-04-24 2009-09-10 株式会社ステムセル研究所 移植用臓器の調製方法
CA2673521C (en) * 2006-10-12 2017-01-17 Ethicon, Inc. Kidney-derived cells and methods of use in tissue repair and regeneration
JP2010509922A (ja) 2006-11-16 2010-04-02 ジェネンテック インコーポレイテッド 腫瘍と関連している遺伝的変異
WO2008066498A1 (en) 2006-12-01 2008-06-05 Agency For Science, Technology And Research Cancer-related protein kinases
AU2008262333B2 (en) * 2007-06-08 2014-07-17 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
WO2010057015A1 (en) 2008-11-14 2010-05-20 Wake Forest University Health Sciences Kidney structures and methods of forming the same
WO2010057013A1 (en) 2008-11-14 2010-05-20 Wake Forest University Health Sciences Selective cell therapy for the treatment of renal failure
JP5565607B2 (ja) 2009-07-15 2014-08-06 国立大学法人 東京大学 敗血症又は多臓器不全の予後診断方法及び予後診断用キット

Also Published As

Publication number Publication date
AU2017202897A1 (en) 2017-05-25
US9192629B2 (en) 2015-11-24
KR20170045385A (ko) 2017-04-26
JP2016028578A (ja) 2016-03-03
US8318484B2 (en) 2012-11-27
KR20180097788A (ko) 2018-08-31
AU2019202099A1 (en) 2019-04-18
EP2662440B1 (en) 2018-04-25
JP2021100428A (ja) 2021-07-08
US10105392B2 (en) 2018-10-23
KR102672712B1 (ko) 2024-06-07
AU2020239736A1 (en) 2020-10-15
AU2017202897B2 (en) 2019-04-18
NZ601862A (en) 2014-07-25
AU2009314552A1 (en) 2011-06-30
EP2358375A1 (en) 2011-08-24
US20130149347A1 (en) 2013-06-13
KR20220112862A (ko) 2022-08-11
AU2019202099B2 (en) 2020-10-08
KR102428795B1 (ko) 2022-08-04
JP5974233B2 (ja) 2016-08-24
HK1197267A1 (en) 2015-01-09
WO2010056328A9 (en) 2011-05-19
KR20110100213A (ko) 2011-09-09
US20240108657A1 (en) 2024-04-04
US20110117162A1 (en) 2011-05-19
EP3388509A1 (en) 2018-10-17
EP2662440A1 (en) 2013-11-13
NZ593207A (en) 2012-10-26
AU2024203036A1 (en) 2024-05-30
KR102357077B1 (ko) 2022-01-27
AU2020239736B2 (en) 2024-02-08
KR101735125B1 (ko) 2017-05-15
EP2358375B1 (en) 2013-07-24
KR101893717B1 (ko) 2018-08-30
AU2009314552B2 (en) 2017-02-02
CN102271692B (zh) 2014-05-21
JP2012508691A (ja) 2012-04-12
CN103937737B (zh) 2023-05-23
JP2018148909A (ja) 2018-09-27
CN103937737A (zh) 2014-07-23
WO2010056328A1 (en) 2010-05-20
US20190117695A1 (en) 2019-04-25
KR20200138830A (ko) 2020-12-10
CN102271692A (zh) 2011-12-07
CA2743459A1 (en) 2010-05-20
US20160206659A1 (en) 2016-07-21
JP2023100876A (ja) 2023-07-19

Similar Documents

Publication Publication Date Title
HK1157190A1 (en) Isolated renal cells and uses thereof
WO2010088633A3 (en) Novel cell lines and methods
MX339769B (es) Sistemas, metodos y composiciones para optimizar injertos enriquecidos con celulas y tejidos.
WO2010096588A3 (en) Cell culture media containing combinations of proteins
WO2009015343A3 (en) Differentiation of multi-lineage progenitor cells to chondrocytes
WO2011133902A3 (en) Cell culture medium comprising small peptides
NZ602201A (en) A novel ethanologenic clostridium species, clostridium coskatii
HK1159397A1 (en) Cell reselection in a wireless communication system
MX2010006169A (es) Enfoques moleculares para la optimizacion de la produccion de biocombustibles.
WO2008122027A3 (en) Novel electrode
EP2264779A4 (en) Solar cell, solar cell string and solar cell module
BR112013017632A2 (pt) meio de cultura celular
MX2009011956A (es) Metodos para detectar contaminantes organicos en la pulpa y fibra.
WO2011019871A3 (en) Biochars, methods of using biochars, methods of making biochars, and reactors
WO2010111659A8 (en) Tumor-initiating cells and methods for using same
WO2011056644A3 (en) Anti-glp-1r antibodies and their uses
WO2008118392A3 (en) Synthetic cell platforms and methods of use thereof
EP2786999A4 (en) SULFONATE COMPOUND, POLYMER ELECTROLYTE MEMBRANE COMPRISING SAME, AND FUEL CELL COMPRISING SAME
TN2010000270A1 (en) Process for the production of algal biomass with a high lipid content
WO2009102569A3 (en) Cell lines and methods for making and using them
BRPI0910122A2 (pt) "método de produção de biomassa de levedura"
WO2015004403A3 (fr) Procede de culture cellulaire decouple
EP2292691A4 (en) DISPERSION OF AN ORGANIC-INORGANIC COMPLEX, CELL CULTURE SUBSTRATE MANUFACTURED BY USE OF THE DISPERSION, AND METHOD OF MANUFACTURING THEREOF
WO2011059920A3 (en) Methods of generating neural stem cells
EP2343361A4 (en) CELL CULTURE KIT, SCREENING METHOD, AND METHOD FOR MANUFACTURING THE CELL CULTURE KIT